Molecular Therapy: Nucleic Acids (Jun 2024)

Effective intravitreal gene delivery to retinal pigment epithelium with hyaluronic acid nanospheres

  • Ryan Crane,
  • Mustafa S. Makia,
  • Stephanie Zeibak,
  • Lars Tebbe,
  • Larissa Ikele,
  • Christian Rutan Woods,
  • Shannon M. Conley,
  • Ghanashyam Acharya,
  • Muna I. Naash,
  • Muayyad R. Al-Ubaidi

Journal volume & issue
Vol. 35, no. 2
p. 102222

Abstract

Read online

Inherited retinal degeneration (IRD) can cause a wide range of different forms of vision loss and blindness, and in spite of extensive advancements in gene therapy research, therapeutic approaches for targeting IRDs are still lacking. We have recently developed an approach for the intravitreal co-delivery of hyaluronic-acid nanospheres (HA-NSs) with sulfotyrosine (ST), effectively reaching the outer retina from the vitreal cavity. Here, our goal was to understand whether DNA-filled HA-NSs could generate gene expression in the outer retina. TxRed-labeled HA-NSs were compacted with plasmid DNA carrying a GFP reporter gene and intravitreally injected into the mouse retina. Follow-up at 4 weeks showed widespread gene expression in the outer retina and reduced, albeit present, expression at 8 weeks post-injection. Further analysis revealed this expression to be largely localized to the retinal pigment epithelium (RPE). These data show that intravitreal delivery of HA-NSs is a promising non-viral platform for the delivery of therapeutic genes and can generate pan-tissue, persistent gene expression in the RPE.

Keywords